Lucio Annunziato
Director/Board Member at ARTERRA BIOSCIENCE S.P.A.
Profile
Lucio Annunziato is an Independent Director at Arterra Bioscience SpA, and a Member of both the American Society for Pharmacology & Experimental Therapeutic and the British Pharmacological Society.
He was a Member of the Academic Governing Board at Università degli Studi di Napoli Federico II from 2011 to 2014, and served as President of the Società Italiana Di Neuroscienze from 2010 to 2012.
Lucio Annunziato active positions
Companies | Position | Start |
---|---|---|
ARTERRA BIOSCIENCE S.P.A. | Director/Board Member | - |
American Society for Pharmacology & Experimental Therapeutic | Corporate Officer/Principal | - |
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Corporate Officer/Principal | - |
Former positions of Lucio Annunziato
Companies | Position | End |
---|---|---|
Università degli Studi di Napoli Federico II | Corporate Officer/Principal | 01/01/2014 |
Società Italiana Di Neuroscienze | President | 01/01/2012 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ARTERRA BIOSCIENCE S.P.A. | Health Technology |
Private companies | 3 |
---|---|
American Society for Pharmacology & Experimental Therapeutic | |
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Miscellaneous |
Società Italiana Di Neuroscienze |
- Stock Market
- Insiders
- Lucio Annunziato